US2018030122A1PendingUtilityA1
Biomarkers for rheumatoid arthritis
Est. expiryMar 21, 2028(~1.7 yrs left)· nominal 20-yr term from priority
G01N 2800/102G01N 33/6854C07K 16/18
41
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the diagnosis of autoimmune disorders, more specifically to the diagnosis of rheumatoid disorders, chronic autoimmune arthritis and even more specifically to the diagnosis of rheumatoid arthritis. A biomarker panel is provided which can be used to detect if a subject has rheumatoid arthritis. Also described are methods of identification of such biomarkers.
Claims
exact text as granted — not AI-modified1 . A method for specifically detecting rheumatoid arthritis in a mammal comprising i) detecting the presence or quantity of at least one antibody in a body fluid derived from said mammal wherein said antibody has a specificity for a polypeptide comprising a sequence selected from the group consisting of SEQ ID NO: 1-14 or a fragment comprising at least 5 consecutive amino acids derived from SEQ ID NO: 1-14 and wherein ii) the presence of said antibody indicates that said mammal suffers from rheumatoid arthritis.
2 . - 27 . (canceled)Join the waitlist — get patent alerts
Track US2018030122A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.